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We investigated epidemiologic and clinical aspects of 
rickettsial diseases in 280 international travelers reported to 
the GeoSentinel Surveillance Network during 1996–2008. 
Of these 280 travelers, 231 (82.5%) had spotted fever 
(SFG) rickettsiosis, 16 (5.7%) scrub typhus, 11 (3.9%) Q 
fever, 10 (3.6%) typhus group (TG) rickettsiosis, 7 (2.5%) 
bartonellosis, 4 (1.4%) indeterminable SFG/TG rickettsio-
sis, and 1 (0.4%) human granulocytic anaplasmosis. One 
hundred ninety-seven (87.6%) SFG rickettsiosis cases 
were acquired in sub-Saharan Africa and were associated 
with higher age, male gender, travel to southern Africa, late 
summer season travel, and travel for tourism. More than 
90% of patients with rickettsial disease were treated with 
doxycycline, 43 (15.4%) were hospitalized, and 4 had a 
complicated course, including 1 fatal case of scrub typhus 
encephalitis acquired in Thailand. 
R
ickettsial diseases are acute and potentially severe 
zoonotic infections caused by obligate intracellular, 
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Learning Objectives
Upon completion of this activity, participants will be able to:
Describe the most common rickettsial diseases in returning international travelers between 1996 and 2008. • 
Identify risk factors associated with higher likelihood of rickettsial disease among returning international travelers. • 
Describe the most common treatment for rickettsial diseases. • 
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Activity Evaluation
1. Which of the following are no longer classiﬁ  ed as 
rickettsial disorders?
A. Ehrlichia and Anaplasma
B. Orientia and Coxiella burnetti
C. Coxiella burnetti and Bartonella
D. Anaplasma and Bartonella
2. A 44-year-old male traveler returning from Tanzania 
presents 7 days after return with fever and respiratory 
symptoms. Among rickettsial diseases to be 
considered, which of the following is most likely to be 
the cause of his illness?
A. Ehrlichiosis
B. Spotted fever group rickettsiosis
C. Bartonellosis
D. Typhus group rickettsiosis
3. Which of the following is least likely to be positively 
and independently associated with spotted fever 
group rickettsiosis in a returning international 
traveler?
A. Travel for business
B. Visit to southern Africa
C. Male gender
D. Travel from March to May
4. Which of the following is the most commonly used 
treatment for rickettsial disease among returning 
international travelers?
A. Tetracycline
B. Minocycline
C. Septra
D. Doxycycline
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